Vantage

Mirati Therapeutics, Inc. (NASDAQ: MRTX) shares were rallying by about 15 percent Thursday as traders circulated word that drugmaker Amgen, Inc. (NASDAQ: AMGN) KRAS G12C inhibitor abstract showed promising data at a huge cancer conference.  What Happened Amgen showcased its oncology...